"Carbamazepine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An anticonvulsant used to control grand mal and psychomotor or focal seizures. Its mode of action is not fully understood, but some of its actions resemble those of PHENYTOIN; although there is little chemical resemblance between the two compounds, their three-dimensional structure is similar.
| Descriptor ID |
D002220
|
| MeSH Number(s) |
D03.633.300.240.127
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Carbamazepine".
Below are MeSH descriptors whose meaning is more specific than "Carbamazepine".
This graph shows the total number of publications written about "Carbamazepine" by people in this website by year, and whether "Carbamazepine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 2 | 0 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carbamazepine" by people in Profiles.
-
Dastgheib L, Rostami F, Gharesi-Fard B, Asadi-Pooya AA, Namjoo S, Tahmasebi F, Hadibarhaghtalab M. Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study. Iran J Med Sci. 2023 Jan; 48(1):70-76.
-
Asadi-Pooya AA, Patel AA, Trinka E, Mazurkiewicz-Beldzinska M, Cross JH, Welty TE. Recommendations for treatment strategies in people with epilepsy during times of shortage of antiseizure medications Epileptic Disord. 2022 10 01; 24(5):751-764.
-
Choi H, Mohit B. Cost-effectiveness of screening for HLA-B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States. Epilepsia. 2019 07; 60(7):1472-1481.
-
Asadi-Pooya AA, Forouzesh M, Eidi H, Mirzaghafour SE. Levetiracetam versus carbamazepine in treatment of rolandic epilepsy. Epilepsy Behav. 2019 05; 94:1-8.
-
Malatack JJ, Doyle D. A Drug Regimen for Progressive Familial Cholestasis Type 2. Pediatrics. 2018 01; 141(1).
-
Deeb S, McKeown DA, Torrance HJ, Wylie FM, Logan BK, Scott KS. Simultaneous analysis of 22 antiepileptic drugs in postmortem blood, serum and plasma using LC-MS-MS with a focus on their role in forensic cases. J Anal Toxicol. 2014 Oct; 38(8):485-94.
-
Mintzer S, Skidmore CT, Sperling MR. B-vitamin deficiency in patients treated with antiepileptic drugs. Epilepsy Behav. 2012 Jul; 24(3):341-4.
-
Mintzer S, Skidmore CT, Rankin SJ, Chervoneva I, Pequinot E, Capuzzi DM, Sperling MR. Conversion from enzyme-inducing antiepileptic drugs to topiramate: effects on lipids and C-reactive protein. Epilepsy Res. 2012 Jan; 98(1):88-93.
-
Asadi-Pooya AA, Asadi-Pooya K. Antinuclear antibodies in children with epilepsy treated by carbamazepine. Epilepsy Res. 2008 Aug; 80(2-3):229-30.
-
Goodman JW, Goldfarb DS. The role of continuous renal replacement therapy in the treatment of poisoning. Semin Dial. 2006 Sep-Oct; 19(5):402-7.